I agree that this site is using cookies. You can find further informations here.
X
Filipa Lynce
101  results:
Search for persons X
?
1

A Subpopulation of Luminal Progenitors Secretes Pleiotrophi..:

Zhang, Mengmeng ; Zhou, Kaiwen ; Wang, Zilin...
Cancer Research.  84 (2024)  11 - p. 1781-1798 , 2024
Link: https://doi.org/10.1158/..
 
?
2

TBCRC 039: a phase II study of preoperative ruxolitinib wit..:

Lynce, Filipa ; Stevens, Laura E. ; Li, Zheqi...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Adjuvant nivolumab, capecitabine or the combination in pati..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

OptimICE-RD: sacituzumab govitecan + pembrolizumab vs pembr..:

Tolaney, Sara M ; DeMichele, Angela ; Takano, Toshimi...
Future Oncology.  , 2024
Link: https://doi.org/10.1080/..
 
?
5

Immunotherapy for Early-Stage Triple Negative Breast Cancer..:

Song, Fei ; Tarantino, Paolo ; Garrido-Castro, Ana...
Current Oncology Reports.  26 (2024)  1 - p. 21-33 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Addressing Residual Disease in HER2-Positive and Triple-Neg..:

Schlam, Ilana ; Dower, Joshua ; Lynce, Filipa
Current Oncology Reports.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Prognosis and treatment outcomes for patients with stage IA..:

Tarantino, Paolo ; Leone, Julieta ; Vallejo, Carlos T....
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Clinicopathological characteristics and eligibility for adj..:

Morganti, Stefania ; Jin, Qingchun ; Vincuilla, Julie...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
9

Author Correction: Adjuvant nivolumab, capecitabine or the ..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
10

Cultural adaptations to a telephone genetic counseling prot..:

Gómez-Trillos, Sara ; Graves, Kristi D ; Fiallos, Katie...
Translational Behavioral Medicine.  13 (2023)  5 - p. 297-308 , 2023
Link: https://doi.org/10.1093/..
 
?
11

SP33. Optimizing Patient Selection for Lympha in Patients w..:

Hyland, Colby J. ; Copeland-Halperin, Libby R. ; Gadiraju, Goutam K....
Plastic and Reconstructive Surgery - Global Open.  11 (2023)  5S - p. 141-142 , 2023
Link: https://doi.org/10.1097/..
 
?
12

Clinical Use of PARP Inhibitors in BRCA Mutant and Non-BRCA..:

, In: Targeting the DNA Damage Response for Cancer Therapy; Cancer Treatment and Research,
Lynce, Filipa ; Robson, Mark - p. 91-102 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Copy Number Variation in Inflammatory Breast Cancer:

Hazra, Aditi ; O'Hara, Andrea ; Polyak, Kornelia...
Cells.  12 (2023)  7 - p. 1086 , 2023
Link: https://doi.org/10.3390/..
 
?
14

D84. Pre-operative Lymphedema Risk Factors in Patients with..:

Hyland, Colby J. ; Copeland-Halperin, Libby R. ; Xiang, David...
Plastic and Reconstructive Surgery - Global Open.  11 (2023)  4S - p. 103-103 , 2023
Link: https://doi.org/10.1097/..
 
?
15

A phase I trial of palbociclib and bosutinib with fulvestra..:

Roy, Tina ; Barrows, Elizabeth ; Mainor, Candace...
Contemporary Clinical Trials Communications.  33 (2023)  - p. 101110 , 2023
Link: https://doi.org/10.1016/..
 
1-15